Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Tauriga Sciences Inc. Includes the Phrase “DRUG TEST SAFE” on Back-Side Graphic Design of Each Individual Tauri-Gum™ Pack | ||
By: Nasdaq / GlobeNewswire - 13 Feb 2019 | Back to overview list |
|
New York, NY, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced the inclusion of the phrase “DRUG TEST SAFE” on the Back-Side graphic design (“Back-Side”) of each individual pack of Tauri-GumTM. The phrase will appear on the lower right section (in green font), above the Company’s logo (directly to the right of the GS1 barcode). The Company believes that this clarification is of significant importance, as this product has been formulated with 0% THC content. As recently disclosed, the Company has implemented quality assurance protocols (“QA protocols”) within the manufacturing process to ensure that this above-referenced standard is strictly adhered to. Each production batch of the Company’s CBD Infused gum, will be independently tested by a 3rd party laboratory. In addition, the Company has opted to package its product in a tamper resistant “blister pack” format. The Company has also included the following instructions on the Back-Side of each Tauri-GumTM pack: “Use only if the foil seal [blister pack] is intact.” The Company is targeting the month of March 2019 for its commercial launch of Tauri-GumTM and is hopeful to generate revenue during this current operating quarter (its 4th Fiscal Quarter of 2019). ABOUT: TAURIGA SCIENCES, INC. Tauriga Sciences, Inc. (TAUG) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com. In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum. This site is being constructed under the following URL address: www.taurigum.com Forward-Looking Statements Attachment CONTACT: Contact: CONTACT INFORMATION Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY 10022 Chief Executive Officer Mr. Seth M. Shaw Email: sshaw@tauriga.com cell # (917) 796 9926 www.tauriga.com |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |